Page last updated: 2024-11-01

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Facial Pain

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Facial Pain in 1 studies

N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.

Facial Pain: Pain in the facial region including orofacial pain and craniofacial pain. Associated conditions include local inflammatory and neoplastic disorders and neuralgic syndromes involving the trigeminal, facial, and glossopharyngeal nerves. Conditions which feature recurrent or persistent facial pain as the primary manifestation of disease are referred to as FACIAL PAIN SYNDROMES.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gao, Y1
Duan, YZ1

Other Studies

1 other study available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Facial Pain

ArticleYear
Increased COX2 in the trigeminal nucleus caudalis is involved in orofacial pain induced by experimental tooth movement.
    Anatomical record (Hoboken, N.J. : 2007), 2010, Volume: 293, Issue:3

    Topics: Animals; Behavior, Animal; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Facial Pain; Grooming; Male;

2010